Anika Therapeutics, Inc. (ANIK) P/E ratio

P/E ratio · fiscal 2021
128.0×

The P/E ratio of Anika Therapeutics, Inc. (ANIK) was 128.0× at the end of fiscal 2021 (December 31, 2021). Figures as of 18 Nov 2026, 12:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio, fiscal 2021
128.0×
Highest on record
128.0×fiscal 2021
Lowest on record
12.1×fiscal 2012
Fiscal years on record
122009–2021

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Anika Therapeutics, Inc. P/E ratio, in more detail

Across the 12 fiscal year-ends on record (2009–2021), the highest was 128.0× in fiscal 2021 and the lowest 12.1× in fiscal 2012.

History · 12 fiscal years

P/E ratio at each fiscal year-end

Anika Therapeutics, Inc. P/E ratio, year by year

Anika Therapeutics, Inc. (ANIK) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
2025——$9.61-$0.76
2024——$16.46-$3.83
2023——$22.66-$5.64
2022——$29.60-$1.02
2021128.0×—$35.83$0.28
2020——$45.26-$1.69
201927.4× 3.7% up$51.85$1.89
201826.5× 3.6% up$33.61$1.27
201725.5× 12.2% up$53.91$2.11
201622.8× 19.9% up$48.96$2.15
201519.0× 17.0% up$38.16$2.01
201416.2× 40.9% down$40.74$2.51
201327.5× 126.5% up$38.16$1.39
201212.1× 23.3% down$9.94$0.82
201115.8× 24.2% down$9.80$0.62
201020.8× 12.6% down$6.67$0.32
200923.8×—$7.63$0.32

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

More on ANIK

Anika Therapeutics, Inc., figure by figure

Anika Therapeutics, Inc. (ANIK) overview: price, valuation and scorecard

Anika Therapeutics, Inc. P/E ratio: questions and answers

What is Anika Therapeutics, Inc.'s P/E ratio?

The P/E ratio of Anika Therapeutics, Inc. (ANIK) was 128.0× at the end of fiscal 2021 (December 31, 2021).

What are the highest and lowest P/E ratio figures on record for Anika Therapeutics, Inc.?

Across the 12 fiscal year-ends on record (2009–2021), the highest was 128.0× in fiscal 2021 and the lowest 12.1× in fiscal 2012.

How is Anika Therapeutics, Inc.'s P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Anika Therapeutics, Inc. it is on record here for 12 fiscal years, 2009 to 2021.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Anika Therapeutics, Inc. (ANIK) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ANIK/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.